Overview
A market data
Price History
A price chart · 1M
- O
- 175.42
- H
- 177.32
- L
- 175.42
- C
- 176.74
- Vol
- 4,606.00
Daily history from Jan 4, 2016
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $175.42
- Previous Close
- $175.47
- Day High
- $177.32
- Day Low
- $175.42
- 52 Week High
- $177.32
- 52 Week Low
- $108.04
- 7 Day Return
- +3.61%
- 30 Day Return
- +15.25%
- 90 Day Return
- +35.92%
- 1 Year Return
- +26.22%
- Daily Notional Volume
- $814.1K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 34.20 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $4.57 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.25 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.7% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 19.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $108.35 – $177.05 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $49.2B · P/B 6.16 · P/S 6.68.
Company News
10 captured
Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGRGlobenewswire Inc ·
Global Oligonucleotide Synthesis Reagents Market Size, Share, and Forecast, 2026-2033 | Therapeutics Demand Fuels 11.9% CAGR and USD 1.75 Billion OpportunityGlobenewswire Inc ·